These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [LATS and other thyroid-stimulating immunoglobulins in the pathogenesis of Basedow's disease]. Pinchera A; Baschieri L Recenti Prog Med; 1976 Dec; 61(6):790-823. PubMed ID: 1037332 [No Abstract] [Full Text] [Related]
4. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity]. Shishiba Y Nihon Rinsho; 1978; 36(5):960-6. PubMed ID: 353330 [No Abstract] [Full Text] [Related]
5. [Etiology of Basedow's disease]. Miyai K Nihon Rinsho; 1971 May; 29(5):1286-93. PubMed ID: 4996745 [No Abstract] [Full Text] [Related]
6. [The pathogenesis of Basedow's disease. Attempt at an immunologic interpretation]. Seif FJ; Heni F Med Welt; 1977 Mar; 28(11):509-14. PubMed ID: 577003 [No Abstract] [Full Text] [Related]
7. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease]. Leövey A Orv Hetil; 1978 Aug; 119(33):2019-21. PubMed ID: 209384 [No Abstract] [Full Text] [Related]
9. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease]. Shishiba Y Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180 [No Abstract] [Full Text] [Related]
10. [LATS and other antibodies against the TSH receptor]. Rodríguez Zapata MM Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881 [No Abstract] [Full Text] [Related]
11. [Myxedema tuberosum atypicum (Jadassohn-Doesserkker, 1916) in the clinical picture of the myxodermias and in the normal course of Graves-Basedow's disease]. Rabello FE; Reis VL; Marques AS; Tendrich M; Cordeiro JG Med Cutan Ibero Lat Am; 1983; 11(6):399-412. PubMed ID: 6366397 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of some immunolgical parmeters in Basedow's disease]. Indiveri F; Barabino A; Di Benedetto G; Solda AM; Puppo F; Ferrini O Arch Maragliano Patol Clin; 1975; 31(2):271-7. PubMed ID: 802377 [No Abstract] [Full Text] [Related]
13. [Etiology of Basedow's disease]. Kumahara U; Fukuchi M Horumon To Rinsho; 1967 Oct; 15(10):834-40. PubMed ID: 4870889 [No Abstract] [Full Text] [Related]
15. [Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)]. Zao WS; Wang SZ Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):119-25. PubMed ID: 6895561 [No Abstract] [Full Text] [Related]
16. [Cellular aspects of the immune response during Basedow's disease]. Clot J Ann Endocrinol (Paris); 1982 Dec; 43(6):548-52. PubMed ID: 6763849 [No Abstract] [Full Text] [Related]
17. [Relation between Basedow's disease and Hashimoto thyroiditis]. Földes J; Takó J; Bános C; Gesztesi E; Juhász J Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742 [No Abstract] [Full Text] [Related]
19. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy. Földes J; Takó J; Bános C; Gesztesi E Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524 [No Abstract] [Full Text] [Related]
20. [ON THE THYROID STIMULATING ACTION OF BLOOD PLASMA FROM PATIENTS WITH BASEDOW'S DISEASE. (THE "LONG ACTING THYROID STIMULATOR" TEST IN BASEDOW'S DISEASE)]. FOELDES J; KRASZNAI I; GYERTYANFFY G Orv Hetil; 1965 May; 106():883-6. PubMed ID: 14305014 [No Abstract] [Full Text] [Related] [Next] [New Search]